Serum ornithine carbamyltransferase reflects hepatic damage in diabetic obese mice

被引:2
作者
Murayama, Hiroshi [1 ]
Ikemoto, Masaki [2 ]
Hamaoki, Masaru [1 ]
机构
[1] Yamasa Corp, Diagnost Dept, Chiba 2880056, Japan
[2] Kyoto Univ, Fac Med, Sch Hlth Sci, Kyoto, Japan
关键词
alanine aminotransferase; mitochondria; non-alcoholic fatty liver disease; ornithine carbamyltransferase; FATTY LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; INSULIN-RESISTANCE; ANIMAL-MODELS; INJURY; ADIPONECTIN; NASH; PURIFICATION; PATHOGENESIS; EXTRUSION;
D O I
10.1111/j.1440-1746.2009.05969.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aim: As ornithine carbamyltransferase (OCT) has proved to be a sensitive serum marker in the detection of hepatotoxicity in several models, it is important to confirm its application to the diagnosis of non-alcoholic fatty liver disease. Methods: C57BL/6, KK-Ta and KK-Ay mice were fed a high-fat diet for 8 weeks and serum enzyme markers were examined. Serum OCT and alanine aminotransferase (ALT) were also measured in diabetic obese ob/ob and db/db mice fed a normal diet. Liver damage in these mice was evaluated by the hepatic content of tumor necrosis factor-alpha. Results: Serum levels of OCT increased in KK-Ay fed a high-fat diet compared with the normal diet-fed group, whereas C57BL/6 and KK-Ta mice were not affected. In ob/ob mice, the relative increase was always greater in OCT than in ALT. In contrast, in db/db mice, the relative increase was always greater in ALT. Hepatic tumor necrosis factor-alpha was significantly elevated in ob/ob mice, but not in db/db mice. Conclusions: Serum OCT seemed to reflect tumor necrosis factor-alpha-mediated hepatic damage when compared with ALT in diabetic obese mice and could be useful in the application for non-alcoholic fatty liver disease with features of metabolic syndrome, such as obesity and diabetes.
引用
收藏
页码:413 / 419
页数:7
相关论文
共 41 条
  • [11] HESTON WE, 1962, JNCI-J NATL CANCER I, V29, P197
  • [12] Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver
    Honda, H
    Ikejima, K
    Hirose, M
    Yoshikawa, M
    Lang, T
    Enomoto, N
    Kitamura, T
    Takei, Y
    Sato, N
    [J]. HEPATOLOGY, 2002, 36 (01) : 12 - 21
  • [13] Adiponectin and its receptors in non-alcoholic steatohepatitis
    Kaser, S
    Moschen, A
    Cayon, A
    Kaser, A
    Crespo, J
    Pons-Romero, F
    Ebenbichler, CF
    Patsch, JR
    Tilg, H
    [J]. GUT, 2005, 54 (01) : 117 - 121
  • [14] Animal models of steatosis
    Koteish, A
    Diehl, AM
    [J]. SEMINARS IN LIVER DISEASE, 2001, 21 (01) : 89 - 104
  • [15] Leptin is essential for the hepatic fibrogenic response to chronic liver injury
    Leclercq, IA
    Farrell, GC
    Schriemer, R
    Robertson, GR
    [J]. JOURNAL OF HEPATOLOGY, 2002, 37 (02) : 206 - 213
  • [16] LOWRY OH, 1951, J BIOL CHEM, V193, P265
  • [17] Luyckx FH, 2000, DIABETES METAB, V26, P98
  • [18] Novel mechanism of elimination of malfunctioning mitochondria (mitoptosis): Formation of mitoptotic bodies and extrusion of mitochondrial material from the cell
    Lyamzaev, Konstantin G.
    Nepryakhina, Olga K.
    Saprunova, Valeria B.
    Bakeeva, Lora E.
    Pletjushkina, Olga Yu.
    Chernyak, Boris V.
    Skulachev, Vladimir P.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2008, 1777 (7-8): : 817 - 825
  • [19] Apoptosis and necrosis in the liver: A tale of two deaths?
    Malhi, H
    Gores, GJ
    Lemasters, JJ
    [J]. HEPATOLOGY, 2006, 43 (02) : S31 - S44
  • [20] Adiponectin protects LPS-induced liver injury through modulation of TNF-α in KK-Ay obese mice
    Masaki, T
    Chiba, S
    Tatsukawa, H
    Yasuda, T
    Noguchi, H
    Seike, M
    Yoshimatsu, H
    [J]. HEPATOLOGY, 2004, 40 (01) : 177 - 184